BLOG / 🇺🇸 United States / broad market · · daily

US SEC Filings Daily Market Digest — November 04, 2026

Daily USA Market Intelligence

By Gunpowder Editorial ·

10 high priority 40 medium priority 50 total filings analysed

Executive Summary

This Daily USA Market Intelligence digest covers 50 SEC filings from November 4, 2026, revealing a market bifurcated between strong operational performances and significant headwinds from regulatory shifts and sector-specific downturns.

A dominant theme is the acute pressure on cannabis and biotech companies from impending federal restrictions and clinical failures, with RYTHM, Inc. facing a critical regulatory cliff on December 11, 2026, and Royalty Pharma absorbing a $150M impairment from a Phase 3 trial failure. Conversely, the industrial and infrastructure sectors show robust health, led by Vishay's record revenue ($978.9M, +24% YoY) and strong book-to-bill ratios, while L.B. Foster posted a 21.5% revenue surge despite margin compression. The technology landscape is mixed, with Datadog's 35% revenue growth contrasting with Taboola's 6.9% quarterly revenue decline, though both show improved profitability. A wave of 13F-HR filings from institutional managers reveals a massive, passive allocation towards mega-cap tech (Apple, NVIDIA, Alphabet) and broad-market ETFs, providing a macro view of institutional conviction. Key capital allocation signals include Stanley Black & Decker's new $1B buyback authorization and Cencora's 10% dividend hike, while insider activity is notably absent from the filings, suggesting a period of stability or pre-earnings quiet. The most actionable catalysts are the imminent regulatory deadlines for RYTHM and the transformative Shoals Technologies/Array Technologies merger, which targets $2.2-$2.4B in 2027 revenue.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: 425 · 13F · 8-K · 10-Q · Schedule 13G · Schedule 13D

Tracking the trend? Catch up on the prior US SEC Filings Daily Market Digest digest from November 03, 2026.

Investment Signals (12)

  • Record Q3 revenue of $978.9M (+24% YoY), gross margin expansion to 25.5% (from 19.5%), and a 1.29 book-to-bill ratio signal strong demand across semiconductor and passive component markets. Guidance for Q4 revenue of $990M suggests continued momentum.

  • ▲

    Revenue surged 35% YoY to $1.20B, with customers over $100K ARR growing ~20% to 4,860. The launch of Scout 1.0, its first specialized AI model, provides a new growth catalyst. However, Q4 guidance implies a sequential decline, warranting caution.

  • ▲

    Fiscal 2026 adjusted EPS rose 12.3% to $17.97, and management guided FY2027 to $19.40-$19.75 (8-10% growth). The 10% dividend hike to $0.66/share signals strong cash flow confidence despite acquisition-related cost increases.

  • Raised full-year 2026 adjusted EPS guidance to $5.95-$6.25 and free cash flow guidance to $1.0-$1.2B. The new $1B share repurchase authorization, following $250M in buybacks during the quarter, is a strong signal of management's positive outlook on intrinsic value.

  • L.B. Foster Co. (BULLISH)
    ▲

    Net income surged 55.4% YoY and total debt fell 51.1%, dramatically improving the balance sheet. This financial turnaround, despite a 200 bps gross margin contraction, points to successful operational restructuring and deleveraging.

  • While Q3 revenue declined 6.9% YoY, net income soared to $18.4M from $5.2M, driven by a 14.3% reduction in traffic acquisition costs. This demonstrates a powerful pivot to profitability and operational efficiency.

  • Adjusted EBITDA surged 85% YoY to $317M, but this was flattered by $182M of non-recurring ARC token presale revenue. The 61 bps decline in the reserve return rate and flat USDC circulation are underlying bearish signals for the core stablecoin business.

  • ▲

    Net sales declined 7.3% YoY in Q3, and the company recorded a $366M goodwill impairment. While the net loss narrowed, the underlying operating earnings fell 23.1%, indicating deep-seated operational challenges beyond one-time impairments.

  • Despite 15.5% revenue growth, net profit collapsed by 73.7% as cost of revenue surged 34.2%. The company's complete reliance on related-party transactions with Superbee creates a single-point-of-failure risk.

  • Swung from a $21M net income in 9M 2025 to a $31.6M net loss in 9M 2026, driven by the loss of VOWST revenue. Cash burn is severe, with operating cash outflow of $49.2M, drawing down cash reserves from $54.4M to $20.7M.

  • ▲

    Net sales fell 5.7% YoY, and core REPREVE® Fiber sales declined 7.2%. While gross margins improved due to lower input costs, the top-line decline in a key sustainable product line is a bearish signal for the company's core value proposition.

  • NAV per common share declined to $24.57 from $25.24, despite a massive increase in total net assets from common stock issuance. The net change in unrealized losses of -$13.8M and a decline in cash from $137M to $8.2M are significant red flags.

Risk Flags (10)

  • The company withheld Q4 2026 guidance due to impending federal restrictions on hemp-derived THC (Dec 11, 2026) and Illinois restrictions (Nov 12, 2026). With Q3 Adjusted EBITDA declining to $5.9M from $6.4M and a net loss of $0.5M, the business faces an existential risk to its revenue model.

  • The $150M non-cash impairment from the pelacarsen Phase 3 failure highlights the binary risk in royalty investing. The failure of Syndax's Niktimvo in a Phase 2 trial and Revolution Medicines' decision to forgo a $250M funding tranche further compound pipeline risk.

  • With only $20.7M in cash and a nine-month operating cash burn of $49.2M, Seres has less than six months of runway at the current burn rate. The absence of VOWST revenue and a $5.7M impairment charge in Q3 create a liquidity crisis risk.

  • Integrated Media Technology (IMTE) / Nasdaq Compliance Risk [HIGH RISK]
    ▼

    IMTE faces a Nasdaq minimum bid price compliance deadline of December 29, 2026. The proposed share consolidation (1-for-2 to 1-for-10) is a defensive move with no guarantee of success, putting the company's listing at risk.

  • Management explicitly expects continued pressure on metallurgical coal pricing due to soft global steel demand and does not expect a recovery in 2027. Soda ash prices remain low due to Chinese capacity growth, with no Sisecam Wyoming distributions expected near-term.

  • Goodwill fell from $1,679M to $1,288M after impairments and a divestiture. The $366M Q3 impairment suggests potential for further write-downs if the acquired assets or market conditions continue to underperform.

  • Cash and equivalents declined ~36% to $12.5M, and the company carries an $11.5M accrued legal loss and an $8.2M insurance recovery receivable. While EBITDA reached break-even, the GAAP net loss and declining cash position are concerning.

  • The nine-month net loss widened by 20.9% to $195.8M. While cash is ample ($668.4M), the 39.9% surge in nine-month SG&A expenses and a swing in foreign currency from a $25.4M gain to a $4.2M loss indicate deteriorating cost control and financial volatility.

  • The $77.0M 'other income' item in 9M 2026 is a significant, non-recurring boost to profitability. Excluding it, nine-month operating income would be only ~$26.6M, highlighting the fragility of the reported earnings improvement.

  • L.B. Foster Co. / Backlog Decline [MEDIUM RISK]
    ▼

    While current earnings are strong, total backlog declined 5.1% YoY, with Rail backlog down 9.8% and TS&S new orders plunging 59.7% after a large prior-year order. This signals a potential revenue cliff in 2-3 quarters.

Opportunities (10)

  • The definitive stock-for-stock merger targets $2.2-$2.4B in 2027 revenue and $410-$480M in Adjusted EBITDA, with >$100M in annual synergies. Shoals shareholders get 65% of the combined entity, creating a pure-play solar tracking and balance-of-system powerhouse.

  • With a 1.29 book-to-bill ratio and Q4 revenue guidance of $990M (+/- $15M), Vishay is a direct beneficiary of the ongoing industrial and AI infrastructure buildout. The 24% YoY revenue growth and 600 bps gross margin expansion show pricing power and operational leverage.

  • The new three-part reporting structure and evaluation of 'Other' category businesses (MWI Animal Health, Profarma) for strategic alternatives signal a portfolio optimization. The 8-10% EPS growth guidance for FY2027 provides a clear upside target.

  • The proposed transaction with Marvell (MRVL) is a high-materiality event (8/10). While details are scarce, the combination of Lumentum's optical components with Marvell's data infrastructure silicon could create a vertically integrated powerhouse for the AI/data center market.

  • The new $1B share repurchase authorization provides a massive floor under the stock. With $250M already executed in Q3, the company is aggressively returning capital, signaling confidence that the underlying business (ex-tariff refunds) is on a strong footing.

  • XBRL metadata references segments like 'Communications Infrastructure & Data Center' and 'Automotive'. If the unaudited financials show growth in these areas, GF could be a key beneficiary of the AI and EV megatrends, offering a potential turnaround story.

  • The 49th consecutive quarterly distribution ($0.4714/unit) and improved TTM coverage ratio (1.09x) demonstrate a reliable, high-yield income stream for MLP investors. The 20.8% YoY growth in distributable cash flow is a strong tailwind.

  • Ordinary revenue grew 11.8% YoY and net income rose 17.6%, driven by strong operational cash flow (+27.0%). As a Chilean bottler, it offers exposure to resilient consumer demand in an emerging market with a favorable currency translation tailwind.

  • The 14.3% YoY decline in traffic acquisition costs and 5.3% drop in operating expenses suggest the company has found an operating leverage point. If this efficiency is structural, it could lead to sustained margin expansion even with modest revenue growth.

  • The 13F filings reveal concentrated institutional holdings in mega-cap tech (Apple, NVIDIA, Alphabet). This passive, long-only allocation provides a 'smart money' signal that these names are considered core portfolio anchors despite market volatility.

Sector Themes (6)

  • Industrial & Infrastructure Strength
    ◆

    Companies like Vishay (+24% YoY revenue), L.B. Foster (+21.5%), and Stanley Black & Decker (raised guidance) show robust demand. This is contrasted by Owens Corning (-7.3% revenue), indicating a bifurcation within the sector where companies tied to specific end-markets (e.g., solar, rail) outperform those with broader residential/commercial exposure.

  • Cannabis & Biotech Regulatory/Clinical Cliff
    ◆

    RYTHM, Inc. faces an existential regulatory deadline (Dec 11, 2026), while Royalty Pharma and Seres Therapeutics are reeling from clinical failures and product loss. This theme underscores the binary, high-stakes nature of regulatory and clinical catalysts in these sectors, creating both extreme risk and potential for outsized returns for survivors.

  • Tech Sector Profitability vs. Top-Line Growth
    ◆

    Datadog (+35% revenue) and Taboola (-6.9% revenue) both reported improved profitability, but for different reasons. This suggests a sector-wide focus on operational efficiency and AI-driven cost savings, even as top-line growth becomes harder to achieve. The market is rewarding margin expansion over pure revenue growth.

  • Passive Institutional Allocation to Mega-Cap Tech
    ◆

    The 13F-HR filings from 20+ institutional managers (e.g., NEOS, AVALON, AZZAD) reveal a massive, passive allocation towards a core set of mega-cap tech names: Apple, NVIDIA, Microsoft, and Alphabet. This provides a powerful macro-level signal of long-term institutional conviction in these names as core portfolio holdings.

  • Capital Return vs. Reinvestment
    ◆

    A clear divide is visible. Stanley Black & Decker and Cencora are aggressively returning capital via buybacks and dividend hikes, signaling mature, cash-generative businesses. In contrast, companies like uniQure and Seres are burning cash on R&D and operations, reflecting a high-risk, high-reward biotech model. This bifurcation allows investors to choose their risk/reward profile.

  • Commodity & Energy Headwinds
    ◆

    Natural Resource Partners LP explicitly guides for continued weakness in met coal and soda ash through 2027. This provides a clear negative catalyst for investors in these commodity-linked equities, while companies like Vishay, which benefits from industrial demand, show the opposite trend.

Watch List (8)

  • The federal restrictions on hemp-derived THC take effect December 11, 2026, with Illinois restrictions effective November 12, 2026. The company's Q4 guidance is withheld, making this the most critical near-term catalyst in the digest. Watch for pre-emptive strategic moves or a sharp revenue decline.

  • The EGM on November 25, 2026, will decide on a share consolidation to meet Nasdaq's $1.00 minimum bid price by the December 29, 2026 deadline. Failure to pass or an ineffective ratio could lead to delisting.

  • The merger requires shareholder and regulatory approvals. Watch for the filing of the S-4 registration statement and any pushback from shareholders on the exchange ratio or the preferred stock redemption terms.

  • The Form S-4 and joint proxy statement/prospectus have yet to be filed. The market is waiting for key details on deal consideration, exchange ratio, and expected closing timeline, which will determine the arbitrage opportunity.

  • The new three-part reporting structure begins in fiscal Q1 2027. Watch for the first earnings report under this structure to see if the 'Other' category divestitures materialize and how the market prices the new segments.

  • The definitive agreement to acquire Tazapay is expected to close in 2027. Watch for regulatory filings and how this acquisition impacts Circle's non-USDC revenue streams and overall profitability.

  • With a cash balance of $20.7M and a quarterly burn rate of ~$16.4M, Seres is on a short runway. Watch for potential asset sales, licensing deals, or a financing event to extend the timeline.

  • The 6-K filing contains unaudited interim financials. Once the full MD&A is reviewed, watch for segment-specific growth rates in 'Smart Mobile Devices' and 'Data Center' to validate the AI/5G investment thesis.

Filing Analyses (50)
Integrated Media Technology Ltd 6-K mixed materiality 7/10

03-11-2026

Integrated Media Technology Limited (IMTE) has called an Extraordinary General Meeting for 25 November 2026 to seek shareholder approval for a share consolidation at a ratio between 1-for-2 and 1-for-10, with the exact ratio to be set by the Board, effective no later than 31 July 2027. The consolidation is intended to restore compliance with Nasdaq's US$1.00 minimum bid price requirement, with the compliance deadline currently set at 29 December 2026. The filing notes that there is no assurance the consolidation will sustain a higher share price or achieve the desired results.

  • · Consolidation ratio range: not less than 1-for-2 and not more than 1-for-10, exact whole-number ratio set by the Board
  • · Consolidation must take effect no later than 31 July 2027
  • · Record date for voting entitlement: 27 October 2026 at 12:30pm ACDT
  • · Proxy forms must be received at least 48 hours before the meeting
  • · Fractional entitlements will be rounded down to the nearest whole share
  • · Warrants and convertible notes will have exercise prices and share counts adjusted under their terms
  • · Company states the consolidation will not change its balance sheet or shareholder rights, but total market capitalization may fall if the post-split price declines
  • · If shareholders do not approve and compliance is not regained, shares are likely to be delisted from the Nasdaq Capital Market, which could also impair financing ability
  • · No capital gains tax event expected for shareholders holding on capital account; shareholders should consult advisers
Lumentum Holdings Inc. 425 neutral materiality 8/10

03-11-2026

Lumentum Holdings Inc. (LITE) publicly communicated via LinkedIn on November 2, 2026 about a proposed transaction with Marvell Technology Inc. (MRVL). Marvell intends to file a Form S-4 registration statement including a joint proxy statement/prospectus, to be mailed to stockholders of both companies after SEC effectiveness. The filing consists primarily of required legal disclosures (forward-looking statement cautions, participant information, and no-offer language) and does not disclose deal consideration, exchange ratio, valuation, expected closing timeline, or synergy figures.

  • · Marvell will issue shares of its common stock in the Transaction, with a Form S-4 and joint proxy statement/prospectus to be filed with the SEC.
  • · Marvell's 2026 proxy statement was filed May 13, 2026; Marvell's FY2026 10-K (fiscal year ended January 31, 2026) was filed March 11, 2026.
  • · Lumentum's 2026 annual meeting proxy statement was filed October 6, 2026, and its most recent 10-K is referenced with a date of June 27, 2026.
  • · Forward-looking risks cited include ability to secure stockholder and regulatory approvals, retention of key personnel, integration execution, realization of expected synergies, transaction costs, and financing availability.
ROBO.AI INC. 6-K mixed materiality 6/10

04-11-2026

Robo.ai Inc. (Nasdaq: AIIO) reaffirmed a previously approved 1-for-25 reverse stock split of all its ordinary share classes, effective at market open on November 6, 2026, to regain compliance with the Nasdaq $1.00 minimum bid price requirement under Listing Rule 5550(a)(2). The company states the split will not be accompanied by new financing, and that the trading price is expected to rise proportionately but is not guaranteed to reach 25 times its pre-split level. Share counts fall from 13,817,501 to 552,700 Class A shares and from 222,116,290 to 8,894,680 Class B shares.

  • · Reverse split effective at market open on November 6, 2026; ticker remains AIIO with new CUSIP G6693P130
  • · Convertible note floor prices will be adjusted proportionately by a factor of 25
  • · No accompanying financing; company has no current plans for new variable rate equity financing near term, favoring supply chain financing or subsidiary-level raises
  • · Fractional shares will be aggregated and sold where possible, with proceeds distributed to shareholders
  • · Filing is a 6-K for the month of November 2026; registrant is a foreign private issuer headquartered in Dubai, UAE
Beverly Hills Private Wealth, LLC 13F-HR neutral materiality 3/10

04-11-2026

Beverly Hills Private Wealth, LLC (CIK 0001965710, Beverly Hills, CA) filed a Form 13F-HR on November 4, 2026 for the quarter ended September 30, 2026, disclosing its equity and fund holdings as an institutional investment manager. The filing lists a broad portfolio spanning mega-cap technology (Apple, Alphabet, Amazon, Broadcom), financials (Berkshire Hathaway, Charles Schwab, American Express), energy (Chevron, ExxonMobil, Cenovus), and numerous ETFs and closed-end municipal bond funds. The filing is a holdings disclosure only; it contains no period-over-period comparison, so no performance trend can be assessed from this document.

  • · Filing covers the quarter ended September 30, 2026 and was filed November 4, 2026 by an investment manager based at 350 S. Beverly Drive, Suite 360, Beverly Hills, CA 90212
  • · Holdings include both Sole investment discretion positions and 'OTR' (Other Included Manager 1) positions, with Avise Financial Cooperative, Inc. (CIK 0002013342) identified as a co-reporting/other included manager
  • · Calls options are reported on Charles Schwab (5,000 shares) and Chevron (200 shares), indicating some derivative exposure
  • · Apartment Investment & Management Co. (Class A) reports a sole-discretion position of 692,661 shares, among the larger share-count positions in the excerpt
  • · The excerpt is truncated; the full information table and total portfolio value are not included in the provided content, so aggregate AUM and total position count cannot be determined
HOERTKORN RICHARD CHARLES 13F-HR neutral materiality 3/10

04-11-2026

Richard Charles Hoertkorn, a Kentfield, California investment manager, filed a Form 13F-HR reporting 69 holdings with a combined reported market value of approximately $146.0 million as of September 30, 2026. The portfolio is concentrated in large-cap technology and financial names, led by Marvell Technology (~$17.2 million), Skydance (~$2.6 million by value reported in the table, though the largest single position by share count is Skydance at 252,408 shares), Apple (~$12.5 million), Alphabet Class A (~$13.9 million) and Microsoft (~$13.8 million). Because a 13F reports positions only and not period-over-period changes, no YoY or QoQ performance comparison is available from this filing.

  • · Filing reports 69 positions with aggregate value of approximately $146.0M as of 09/30/2026; filed 11/04/2026 (accession 0001598177-26-000005).
  • · Concentration: Marvell Technology is the largest disclosed position by value (~$17.2M), followed by Alphabet Class A (~$13.9M) and Microsoft (~$13.8M).
  • · Skydance holds the largest share count (252,408 shares, ~$2.6M), while several positions are very small (e.g., Hasbro 1 share, Churchill Downs 1 share, Versant Media 1 share).
  • · Holdings are held on a sole-discretion, sole-voting basis per the information table (SOLE investment discretion for all lines).
GreatBanc Trust CO 13F-HR neutral materiality 3/10

04-11-2026

GreatBanc Trust CO filed a Form 13F-HR on November 4, 2026 disclosing its equity and ETF holdings as of September 30, 2026, covering 109 securities with a reported total portfolio value of approximately $166,993,042 (in thousands, i.e., ~$166.99B per the reporting convention). The portfolio is heavily concentrated in broad-market index and ETF vehicles, including large positions in Vanguard S&P 500 ETF, Vanguard Dividend Appreciation, and Vanguard Mid-Cap/Small-Cap ETFs. The filing does not disclose period-over-period changes, so no performance trend can be assessed from this document alone.

  • · Portfolio is predominantly ETF/index-fund based, with the large majority of value in passive broad-market, dividend, and small/mid-cap vehicles rather than single-stock positions
  • · Largest single-stock positions by value include Apple, Nvidia, Microsoft, and Alphabet, though each is modest relative to the ETF holdings
  • · Nearly all holdings are reported as sole voting/investment authority (SOLE); shared (DFND) positions are small by comparison
  • · Filing is an 'OTHER' manager-type 13F-HR with a single reporting manager and no other included managers listed
  • · No prior-period comparison is provided in this filing; changes in holdings must be assessed against the prior 13F filing
STANLEY BLACK & DECKER, INC. 8-K mixed materiality 8/10

04-11-2026

Stanley Black & Decker reported 3Q 2026 net sales of $3.7 billion, down 1% year over year but up 4% organically, with volume up 6% offset by pricing down 2% and portfolio changes down 4%. GAAP EPS was $1.83 and adjusted EPS $2.31, both boosted by roughly $0.67 from net IEEPA tariff refunds, and the company raised 2026 GAAP EPS guidance to $5.45–$5.85 and adjusted EPS guidance to $5.95–$6.25 while lifting free cash flow guidance to $1.0–$1.2 billion. Engineered Fastening sales fell 21% (CAM divestiture drove -22%) and its automotive results missed expectations, while a new $1 billion share repurchase authorization was approved after $250 million was executed in the quarter.

  • · Excluding the tariff refund benefit of ~430bps on gross margin and ~$0.67 on EPS, underlying results were weaker than headline figures suggest; SG&A rose 310bps as a percentage of sales, partly from costs tied to the refunds
  • · Engineered Fastening automotive results were below expectations and segment margin fell 110bps on an adjusted basis
  • · GAAP EPS guidance range is wide, with a $0.40–$0.50 gap to adjusted EPS driven by footprint and cost-action charges
  • · Q3 included a $20.4M loss on sale of a small Engineered Fastening business and $19.7M asset impairment charge
  • · Board leadership changed October 1, 2026, with Debra Crew becoming Independent Chair
Pharmaceutical Resource Technology, Inc. 10-Q mixed materiality 5/10

04-11-2026

Pharmaceutical Resource Technology, Inc. reported 9-month revenue of $8.89M for the period ended September 30, 2026, up 15.5% from $7.69M a year earlier, with net profit falling 73.7% to $0.13M from $0.51M as cost of revenue rose 34.2% and G&A increased 9.7%. Q3 2026 showed a sharp swing to profitability, with net profit of $0.46M versus a $0.37M loss in Q3 2025, driven by a 44.0% revenue increase and lower G&A. All revenue and most expenses are related-party transactions with Superbee.

  • · 9-month cost of revenue rose 34.2% (from $3.54M to $4.75M), outpacing 15.5% revenue growth and compressing gross profit by 0.3% to $4.14M
  • · Gross profit for 9 months was essentially flat, declining from $4.15M to $4.14M
  • · Cash flow from operations rose to $2.66M from $2.19M, while cash balance nearly doubled to $5.15M despite $0.36M in intangible asset purchases
  • · Repayment of $2.80M in debt owed to directors in 2025 did not recur in 2026, and no new equity or loan proceeds were raised in 2026
  • · Related-party exposure is significant: Superbee accounts for all revenue, most cost of revenue and G&A, and a $1.00M receivable and $0.09M trade payable
  • · Net profit in the 9-month period was reduced by a $5,830 income tax provision in 2026, versus none in 2025
  • · Q3 2026 G&A fell 18.0% YoY to $1.17M, which drove the Q3 profit swing despite a 44.0% revenue increase
RYTHM, Inc. 8-K mixed materiality 9/10

04-11-2026

RYTHM, Inc. reported Q3 2026 revenue from continuing operations of $23.9 million, up 4% sequentially from $23.0 million, with a net loss of $0.5 million and Adjusted EBITDA of $5.9 million, down from $6.4 million in the prior quarter. The company withheld Q4 2026 guidance because forthcoming federal restrictions on hemp-derived THC products take effect December 11, 2026, with Illinois restrictions effective November 12, 2026. Green Thumb Industries will consolidate RYTHM's results beginning October 10, 2026, following removal of the 49.99% beneficial ownership limitation.

  • · Income tax benefit of $26.8M recognized in nine months 2026 drove the nine-month net income of $20.6M; Q3 2026 itself had no tax benefit and a net loss of $0.5M.
  • · Q3 2026 Adjusted EBITDA declined to $5.9M from $6.4M sequentially, a decline not highlighted in the headline bullet points.
  • · Operating expenses rose 69% year-over-year to $17.4M, while gross profit rose to $18.4M, reflecting a much larger revenue base than Q3 2025 (which was $4.0M).
  • · Other expense, net was $(1.5)M in Q3 2026, with interest expense of $1.7M, keeping the company loss-making at the pre-tax level.
  • · Related party debt of $72.0M classified as current at September 30, 2026, representing a significant near-term obligation relative to $48.2M cash.
  • · Q4 2026 outlook withheld due to federal and Illinois regulatory uncertainty, a material forward-looking risk.
  • · Shares outstanding of approximately 2.2M at quarter end versus 7.7M weighted average shares in Q3, with 11.2M warrants and 3.0M convertible-note shares outstanding, indicating substantial dilution potential.
  • · Green Thumb will consolidate RYTHM beginning October 10, 2026, after removal of the 49.99% beneficial ownership limitation approved by stockholders on August 10, 2026.
GLOBALFOUNDRIES Inc. 6-K neutral materiality 5/10

04-11-2026

GLOBALFOUNDRIES filed a 6-K on November 4, 2026 furnishing its unaudited interim condensed consolidated financial statements as of September 30, 2026 and December 31, 2025, along with MD&A for the three and nine months ended September 30, 2026 and 2025. The filing content provided is limited to the cover page, signature block, and XBRL metadata, so the actual revenue, earnings, and segment figures could not be verified from this text and no financial performance direction (growth, decline, or flat) can be confirmed.

  • · Filing is a Form 6-K (Commission File Number 001-40974) with Exhibit 99.1 containing the interim financial statements and MD&A; the company is a Foreign Private Issuer that files annual reports on Form 20-F.
  • · XBRL metadata references segments including Smart Mobile Devices, Communications Infrastructure & Data Center, Home & Industrial IoT, Automotive, Manufacturing Services, and Technology Services.
  • · XBRL metadata references subsidiary and transaction-related entities (Synopsys, MIPS Holdings, Micro Foundry, Silicon Manufacturing Partners, InfiniLink) that may relate to acquisitions or dispositions, but the filing body does not describe them.
Datadog, Inc. 8-K mixed materiality 8/10

04-11-2026

Datadog reported Q3 2026 revenue of $1.20 billion, up 35% year-over-year, with GAAP operating margin of 6% and non-GAAP operating margin of 28%. Customers with ARR of $100,000 or more rose about 20% to roughly 4,860, and the company launched Scout 1.0, its first specialized AI model. Q4 and full-year 2026 guidance was issued, with Q4 revenue of $1.19 billion to $1.20 billion, which implies a sequential decline at the midpoint versus Q3's $1.20 billion.

  • · GAAP net income per diluted share was $0.32 versus non-GAAP net income per diluted share of $0.81
  • · Q4 2026 non-GAAP net income per share guidance is $0.69 to $0.71
  • · FY 2026 non-GAAP net income per share guidance is $2.73 to $2.75
  • · Datadog earned a Leader designation in the 2026 Forrester Wave for AIOps Platforms, its second consecutive year
  • · Gartner recognized Datadog as the 'Company to Beat' for observability platforms in its 2026 AI Vendor Race report
  • · Non-GAAP reconciliation to GAAP guidance was not provided, citing variability in stock-based compensation and employer payroll taxes
uniQure N.V. 10-Q mixed materiality 7/10

04-11-2026

uniQure N.V. reported Q3 2026 total revenues of $5.2 million, up 40.4% from $3.7 million in Q3 2025, driven by higher license revenues ($5.2M vs. $3.6M, +45.0%). However, the net loss widened to $61.2 million from $80.5 million a year earlier (a 24.0% improvement), while the nine-month net loss rose to $195.8 million from $161.9 million (+20.9%). Operating expenses increased 10.1% in the quarter to $59.7 million, with SG&A up 23.1% while R&D rose only 3.4%; nine-month R&D fell 6.8%, but nine-month SG&A rose 39.9%. Cash, cash equivalents and investment securities totaled about $668.4 million at September 30, 2026 (cash $98.4M, current investments $570.0M, non-current investments $100.0M), versus $622.5 million at year-end 2025, supported by a $242.7 million follow-on offering in the nine months.

  • · Other income fell sharply to $4.9M for nine months 2026 from $12.4M in 2025, while other non-operating losses widened to $13.1M from $7.2M.
  • · Foreign currency swung from a $25.4M gain in 9M 2025 to a $4.2M loss in 9M 2026.
  • · Income tax expense for Q3 2026 was $0.7M versus $8.6M in Q3 2025, a decline of about 92%.
  • · Royalty financing liability grew to $502.1M from $478.7M, with $38.7M of interest expense accrued in 9M 2026 against $15.4M of royalty payments.
  • · Accumulated deficit reached $1.52B, up from $1.33B at year-end 2025.
  • · Pre-funded warrant liability was fully settled by year-end 2026 (from $12.6M at Dec 31, 2025), converted into 526,314 shares.
VISHAY INTERTECHNOLOGY INC 8-K mixed materiality 8/10

04-11-2026

Vishay reported record third-quarter 2026 revenue of $978.9 million, up 24% year over year from $790.6 million, with gross margin expanding to 25.5% (from 19.5%) and diluted EPS of $0.37 (versus a $(0.06) loss a year earlier). Sequentially, revenue rose 10% from $888.6 million and gross margin improved from 23.3%. Management guided fourth-quarter 2026 revenue to $990 million ± $15 million and gross margin to 26.0% ± 50 basis points. Growth was not uniform across the period: Q3 SG&A rose 17% year over year to $157.2 million, and the company's interest expense fell from $9.5 million to $6.7 million, but the quarter's 'Other' income line swung from $2.3 million income a year ago to a sequential reversal from $(0.8) million to $1.7 million only after the prior quarter's charge, so quarterly comparisons are mixed. The nine-month period also showed mixed signals, with operating cash flow up sharply but capex rising 42%.

  • · Book-to-bill was 1.29 overall, 1.28 for semiconductors and 1.31 for passive components
  • · Q3 2026 included no tariff refund effect; Q2 2026 revenue and cost of products sold were each reduced by $30.0M for tariff refunds passed through, with no gross profit impact
  • · Q3 2026 operating income of $92.2M compared with $19.1M a year earlier, and $53.5M in Q2 2026
  • · Q3 2026 income tax expense of $28.3M compared with $19.8M a year earlier despite higher pre-tax income
  • · Long-term debt fell to $735.5M from $950.9M at year-end 2025, after $219.0M of net revolver repayments and an $830.3M follow-on equity offering
  • · Nine-month 2026 net cash from operations rose to $314.8M from $34.9M, but nine-month 2026 capex of $253.4M increased 42% year over year
  • · Cash and equivalents more than doubled to $1,139.9M from $515.0M at December 31, 2025
  • · Quarterly cash dividend held at $0.10 per share, unchanged year over year
Owens Corning 10-Q mixed materiality 8/10

04-11-2026

Owens Corning reported a Q3 2026 net loss of $250M (vs. a $494M loss in Q3 2025) on net sales of $2,489M, down 7.3% YoY from $2,684M. The quarter included a $366M goodwill impairment and a $77M intangible assets impairment. For the nine months, net sales declined 5.7% to $7,510M and net loss narrowed to $127M from $225M, aided by the $364M proceeds from the Glass Reinforcements divestiture; however, gross margin fell 18.0% to $1,918M and operating earnings fell 23.1% to $450M.

  • · Q3 2026 basic and diluted loss per share was $(3.18), vs. $(5.92) in Q3 2025; nine-month diluted loss per share was $(1.61) vs. $(2.63)
  • · Goodwill fell from $1,679M at Dec 31, 2025 to $1,288M at Sept 30, 2026, reflecting impairments and the divestiture
  • · Long-term debt (current + non-current) declined to roughly $4,789M from $5,122M after $400M of debt payments in the nine months
  • · Treasury stock purchases of $502M in the nine months (about 3.8M shares) continued despite the net loss
  • · Q3 2026 income tax expense fell to $33M from $102M, while nine-month tax expense was $150M vs. $300M
  • · Discontinued operations produced a nine-month after-tax loss of $229M (vs. $318M), including a $183M loss from classification as discontinued operations
Platt Wealth Management LLC 13F-HR neutral materiality 3/10

04-11-2026

Platt Wealth Management LLC (San Diego, CA; SEC file no. 028-26126) filed its Form 13F-HR for the quarter ended September 30, 2026, reporting 64 holdings with an aggregate reported value of $128,537 thousand (approximately $128.5 million). The portfolio is concentrated in broad-market equity and bond ETFs, with Capital Group Dividend Value ETF (401,667 shares), Monster Beverage (192,668 shares), and Capital Group Fixed Income Municipal High Income ETF (265,989 shares) among the largest positions by share count. The filing contains no prior-period comparison, so quarter-over-quarter changes cannot be assessed from this document alone.

  • · Holdings are reported as 100% sole investment discretion (no shared or other-manager discretion), with zero voting-authority allocations shown in the filing.
  • · Largest position by reported value is not identifiable from the table alone; by share count, Capital Group Dividend Value ETF (401,667 shares) and Monster Beverage (192,668 shares) lead.
  • · Portfolio mixes individual equities (e.g., Apple, Microsoft, NVIDIA, Alphabet, Amazon) with a substantial ETF and municipal bond fund allocation.
  • · Filing reports a filing-agent contact (Cindi Hill, 619-795-5986) and an effective date of November 4, 2026, with a total public document count of 2.
5th Street Advisors, LLC 13F-HR neutral materiality 3/10

04-11-2026

5th Street Advisors, LLC (CIK 0001911026, Southport, CT) filed a Form 13F-HR for the quarter ended September 30, 2026, disclosing its equity and ETF holdings as of that date. The reported portfolio totals $247,848,200 across 75 information-table entries, with all positions held under sole investment discretion. The filing is a routine quarterly holdings disclosure, with no reported trades, acquisitions, or regulatory actions; period-over-period comparison is not available from this filing alone.

  • · Holdings are concentrated in ETFs and index funds, with the largest positions in Vanguard All-World ex-US, J.P. Morgan Short Duration Core, and FlexShares/Global X-type income and infrastructure funds
  • · Several positions are reported with options: a SPDR Gold Trust call (8,000 units) and put (2,000 units) and the holding is reported as PRN call/put, which may warrant review of option-related disclosure
  • · Reported positions include a single share of Berkshire Hathaway Class A stock valued at $747,005, an unusual small-quantity line item
  • · All positions are reported under sole investment discretion with no shared or other-manager voting or investment authority
Taboola.com Ltd. 10-Q mixed materiality 7/10

04-11-2026

Taboola.com Ltd. reported Q3 2026 revenues of $462.3M, down 6.9% from $496.8M in Q3 2025, while net income rose to $18.4M from $5.2M. Nine-month revenues grew 1.2% to $1,405.5M and net income swung to $81.7M from a $7.9M loss, aided by a $77.0M other income item recognized in the first nine months of 2026. Performance is mixed: profitability improved sharply, but top-line revenue declined in the quarter and gross margin/operating expense trends require context.

  • · Q3 2026 operating expenses fell to $125.4M from $132.5M, a 5.3% decline, with sales and marketing down 7.7% and R&D down 3.1%.
  • · Traffic acquisition cost fell 14.3% YoY in Q3, while other cost of revenues declined 4.1%, driving the gross profit increase despite lower revenue.
  • · Nine-month 2026 results include a $77.0M other income, net item; excluding it, nine-month operating income would be about $26.6M versus a $0.3M operating income in 2025.
  • · Finance expense for nine months 2026 was $2.9M versus $6.5M in 2025, and income tax expense rose to $18.9M from $1.6M.
  • · Shares outstanding declined about 8.7% YoY in Q3 weighted-average basic shares, reflecting $94.6M of nine-month repurchases.
  • · Q3 2026 comprehensive income was $16.5M versus $4.0M in Q3 2025, with accumulated other comprehensive loss of $0.4M at period end.
Circle Internet Group, Inc. 8-K mixed materiality 8/10

04-11-2026

Circle reported Q3 2026 results with total revenue and reserve income of $865M (+17% YoY), adjusted EBITDA of $317M (+85% YoY), and net income from continuing operations of $226M (+5% YoY). Growth was flattered by $182M of ARC token presale revenue; reserve income fell 8% YoY on a 61 bps lower reserve return rate, and USDC end-of-period circulation was flat at $73.9B. The company also announced a definitive agreement to acquire Tazapay, expected to close in 2027.

  • · Operating expenses rose 16% YoY to $245M, driven by G&A, D&A, IT infrastructure, and marketing, partly offset by lower stock-based compensation
  • · Net income margin compressed 285 bps YoY to 26%, and the reserve return rate declined 61 bps to 3.5%
  • · Total revenue growth excluding the $182M ARC presale would be substantially lower than the reported 17%
  • · Subscription and services revenue declined year over year
  • · Binance is investing $100M in equity alongside a renewed partnership
  • · Stablecoin market share declined 183 bps YoY to 27% at period end
  • · Circle's FY2026 guidance was unchanged, including $310-330M other revenue (incl. ARC presale), 41.7-43.7% RLDC margin, and $570-585M adjusted operating expenses
Cencora, Inc. 8-K mixed materiality 8/10

04-11-2026

Cencora reported fiscal Q4 2026 revenue of $88.4B (up 5.5% YoY) and fiscal 2026 revenue of $337.4B (up 5.0%). Q4 GAAP diluted EPS was $2.71 versus $(1.75) a year ago, while adjusted diluted EPS rose 21.4% to $4.66; full-year adjusted EPS was $17.97 (up 12.3%). Management guided fiscal 2027 adjusted diluted EPS to $19.40–$19.75 (8–10% growth), introduced new reportable segments, and raised the quarterly dividend 10% to $0.66, while also disclosing a pending acquisition of American Oncology Network and a Profarma stake sale. Results are strong overall, but GAAP operating expenses and interest costs rose and some segments and metrics were flat or softer.

  • · Q4 FY2026 GAAP operating expenses fell 8.2% YoY, but adjusted operating expenses rose 23.5% due to the OneOncology acquisition
  • · Q4 FY2026 net interest expense rose $58.5M (about 75%) YoY from senior notes and term loans used to fund OneOncology
  • · Q4 GAAP effective tax rate was 32.8% versus an adjusted rate of 20.2%, driven by discrete tax items
  • · U.S. Healthcare Solutions revenue growth was partly offset by manufacturer price declines on certain brand drugs and lower sales to a large mail-order customer
  • · Q4 International constant-currency revenue grew 7.8% and operating income 18.9%, above reported figures
  • · U.S. Consulting Services was divested in April 2026, weighing on Other segment consulting sales
  • · Profarma stake sale expected to close in Q1 FY2027
  • · Quarterly dividend payable November 30, 2026 to holders of record on November 13, 2026
  • · New reportable segments effective Q1 FY2027: Pharmaceutical Distribution and Services, Specialty Pharmaceutical and Provider Services, and Other
Sparta 24 Ltd. 13F-HR neutral materiality 4/10

04-11-2026

Sparta 24 Ltd. (CIK 0001967706, Tirat Hacarmel, Israel) filed a Form 13F-HR on November 4, 2026 reporting its institutional equity holdings as of September 30, 2026. The filing lists 24 positions with an aggregate reported value of approximately $90.5 million, with all positions held with sole investment discretion. The portfolio is concentrated in fintech, emerging-market financials, and homebuilders, led by UP Fintech Holding and an iShares MSCI UAE ETF position.

  • · Filing covers the quarter ended September 30, 2026, with a fiscal year end of December 31; signed by director Alon Gonen on November 4, 2026.
  • · All 24 positions are reported with sole investment discretion and no shared or other-manager voting/investment authority.
  • · Top three positions by value (UP Fintech, iShares MSCI UAE ETF, Klarna) account for roughly 60% of the reported total of about $90.5M.
  • · Holdings include several Israeli-linked and emerging-market names (Taboola, ZIM, Genius Group, UP Fintech, PagSeguro, XP, Stoneco, dLocal), reflecting a concentration in fintech and emerging-market financial exposure.
  • · Several positions are sizable relative to the filer's total portfolio, and the list includes a homebuilder pair (KB Home, LGI Homes) and an insurance-tech name (Lemonade) alongside fintech holdings.
CS Disco, Inc. 8-K mixed materiality 7/10

04-11-2026

CS Disco reported Q3 2026 total revenue of $45.3 million, up 11% YoY (15% excluding the Q3 2025 contingent matter), with software revenue of $38.6 million, up 10% (13% excluding the contingent matter). The company reached break-even Adjusted EBITDA of $0.1 million, a quarter ahead of schedule, though GAAP net loss was $5.0 million, improved from $13.7 million a year earlier. Full-year 2026 guidance was issued, with Adjusted EBITDA projected at $(6.8) million to $(5.3) million.

  • · Cash and cash equivalents declined about 36% from Dec 31, 2025 to $12.5M, while short-term investments fell to $84.2M
  • · Accrued legal loss of $11.5M and insurance recovery receivable of $8.2M carried on the balance sheet, tied to a legal loss
  • · Accumulated deficit widened to $(365.1)M, and stockholders' equity fell about 6% to $120.0M since year-end 2025
  • · Accounts receivable rose about 27% to $32.4M since Dec 31, 2025, while deferred revenue declined to $4.6M
  • · Full-year 2026 Adjusted EBITDA guidance remains negative at $(6.8)M to $(5.3)M despite Q3 break-even
  • · Q4 2026 Adjusted EBITDA guidance ranges from $0.0M to $1.5M, implying the company expects to stay near break-even
NATURAL RESOURCE PARTNERS LP 8-K mixed materiality 6/10

04-11-2026

Natural Resource Partners L.P. (NYSE: NRP) reported Q3 2026 free cash flow of $44.8 million and free cash flow available for common unitholder and GP distributions of $31.7 million, or $2.34 per common unit, which the board declared as the Q3 2026 distribution. The partnership fully repaid its remaining $13.1 million credit facility balance, leaving $14.3 million of debt maturing in December 2026. Results were mixed: Mineral Rights net income fell $3.9 million year over year, and Soda Ash net income fell $1.7 million, with no Sisecam Wyoming distribution received in either Q3 2025 or Q3 2026.

  • · Metallurgical coal accounted for approximately 70% of coal royalty revenues and approximately 45% of coal royalty sales volumes in Q3 2026
  • · Management expects continued pressure on metallurgical coal pricing due to soft global steel demand and does not expect meaningful pricing changes for thermal coal or metallurgical coal in 2027
  • · Soda ash prices remain low due to capacity growth in China outpacing global demand; NRP does not expect Sisecam Wyoming distributions until the market rebalances, which is not expected near term
  • · Distribution to be paid November 24, 2026 to unitholders of record on November 17, 2026
  • · Foreign investor withholding: distributions treated as 100% effectively connected income, subject to withholding at highest applicable rate plus 10%
Royalty Pharma plc 8-K mixed materiality 7/10

04-11-2026

Royalty Pharma reported Q3 2026 Portfolio Receipts of $890 million, up 9% YoY from $814 million, with Royalty Receipts up 9% to $883 million, and raised full-year 2026 Portfolio Receipts guidance to $3,500 million to $3,550 million. Results were mixed: operating cash flow fell 2% to $686 million, weighted diluted shares declined slightly, Promacta (-75%) and Imbruvica (-24%) declined, and a $150 million non-cash impairment was recorded on pelacarsen after a Phase 3 failure.

  • · Pelacarsen Phase 3 Lp(a)HORIZON trial failed its primary endpoint, triggering a $150 million non-cash impairment
  • · Syndax's Niktimvo failed its Phase 2 MAXPIRe trial in idiopathic pulmonary fibrosis and will not be developed further in IPF
  • · Revolution Medicines elected not to exercise its option for the third royalty funding tranche (up to $250 million)
  • · Total debt fell from $9.2 billion to $8.8 billion after the $380 million term loan was repaid in July 2026
  • · Interest paid, net rose to $167 million in Q3 2026 from $123 million a year earlier
  • · Expected FY2026 FX impact of approximately +1% to Portfolio Receipts
  • · Pharvaris PDUFA date for on-demand deucrictibant set for April 23, 2027
Westlake Chemical Partners LP 8-K mixed materiality 5/10

04-11-2026

Westlake Chemical Partners LP reported Q3 2026 net income attributable to the Partnership of $16.2 million ($0.46 per common unit), up 10.6% from $14.7 million in Q3 2025 and up $2.0 million sequentially. Operating cash flow was $122.2 million, up 16.1% YoY ($105.2 million) but down $7.6 million QoQ on less favorable working capital changes. MLP distributable cash flow rose to $18.0 million (+20.8% YoY), while the TTM coverage ratio improved to 1.09x from 1.04x at Q2 end; the Partnership also declared its 49th consecutive quarterly distribution of $0.4714 per unit. Performance is mixed: earnings, EBITDA and distributable cash flow improved, but nine-month operating cash flow in the statement of cash flows and the Q3 sequential working-capital reversal show weaker quality of cash generation.

  • · Net sales from Westlake Corporation declined 5.3% YoY to $261.9M, while third-party co-products and ethylene sales rose 62.3% to $52.5M, offsetting the decline.
  • · Q3 2026 SG&A expenses rose 12.0% YoY to $8.3M from $7.4M.
  • · Nine-month 2026 operating cash flow of $362.2M rose sharply from $160.1M, but this was driven largely by working capital swings (other balance sheet changes were +$2.6M in 2026 vs -$150.0M in 2025).
  • · Cash distributions to noncontrolling interest in OpCo totaled $237.3M in the first nine months of 2026, up from $180.6M.
  • · Q3 2026 maintenance capital expenditures fell to $15.1M from $24.2M in Q3 2025 and are a key driver of higher distributable cash flow.
  • · Partnership's cumulative distribution coverage ratio since its July 2014 IPO is approximately 1.05x.
  • · Ethylene Sales Agreement: 95% of OpCo ethylene production sold to Westlake at a cash margin of $0.10 per pound, net of operating costs, maintenance capex and turnaround reserves.
FOSTER L B CO 8-K mixed materiality 7/10

04-11-2026

L.B. Foster reported Q3 2026 net sales of $168.0 million, up 21.5% YoY, with net income attributable to the company up 55.4% to $6.8 million and Adjusted EBITDA up 15.1% to $13.1 million. Total debt fell 51.1% to $28.7 million and the Gross Leverage Ratio improved to 0.6x. However, gross margin contracted 200 bps to 20.5%, operating cash flow declined 19.3% to $23.6 million, free cash flow fell 21.0%, and Rail backlog dropped 9.8%, with total backlog down 5.1% YoY.

  • · Global Friction Management Q3 sales fell 9.0% and orders fell 10.2% due to project timing and lower volumes
  • · TS&S Q3 new orders declined 59.7% after a large prior-year UK order
  • · Rail segment Q3 gross margin fell 320 bps to 19.6%, and Rail segment backlog declined 9.8% YoY
  • · Infrastructure Solutions Q3 operating income rose only 5.4%, with Steel Products backlog up 52.6% but Precast backlog down 11.7%
  • · Q3 new orders growth of 35.7% was flattered by a $19M order cancelled in the prior-year period
  • · Trailing twelve-month book-to-bill was 0.98:1.00 company-wide and 0.96:1.00 for Rail, below 1.00
  • · Tew Exit costs of $2.1M weighed on nine-month Rail gross profit
  • · Full-year guidance raised net sales outlook to $570M-$590M and free cash flow range to $20M-$28M, but Adjusted EBITDA range was narrowed to $42M-$45M and guidance excludes Dulworth purchase accounting and transaction costs
C WorldWide Group Holding A/S 13F-HR neutral materiality 3/10

04-11-2026

C WorldWide Group Holding A/S, a Copenhagen-based institutional manager (CIK 0001625244, filer for C WorldWide Asset Management Fondsmaeglerselskab A/S), filed its Form 13F-HR for the quarter ended September 30, 2026, reporting 96 holdings in its information table. The largest positions by reported value include HDFC Bank ADS (7,104,822 shares), Nu Holdings (4,896,136 shares), ICICI Bank ADR (1,867,945 shares) and NextEra Energy (2,353,059 shares), with a broad mix spanning healthcare/biotech, technology, financials and consumer names. The filing is a routine portfolio disclosure and reports no explicit change versus the prior quarter, so period-over-period direction cannot be determined from this document alone.

  • · Filing covers period ending September 30, 2026 and was filed November 4, 2026 under SEC file number 028-16305.
  • · Information table is reported with investment discretion DFND (defined) and no sole/none voting authority is shown in the reported fields.
  • · Concentration: the top emerging-market financial positions (HDFC Bank, ICICI Bank, Nu Holdings, Infosys, Trip.com, Sea Ltd) form a notable share of the book, alongside large US healthcare and technology holdings.
  • · Several healthcare/biotech positions are held in very large share counts relative to typical float, including Coherus Oncology (1,928,464 shares) and Iovance Biotherapeutics (1,260,000 shares).
Compagnie Lombard Odier SCmA 13F-HR neutral materiality 3/10

04-11-2026

Compagnie Lombard Odier SCmA filed a Form 13F-HR combination report with the SEC on November 4, 2026, covering holdings as of September 30, 2026. The filing lists a large equity portfolio across the information table, with the largest reported positions including NVIDIA, Alphabet, Apple, Amazon, Microsoft, Broadcom, Eli Lilly, Visa, Meta Platforms, and ExxonMobil. The filing is a routine quarterly disclosure of 13(f) securities holdings and does not itself report any new corporate action or regulatory proceeding.

  • · The filing is a combination report; the filer is the manager and lists Bank Lombard Odier & Co Ltd, Lombard Odier (Europe) S.A., and affiliated asset managers as other included managers.
  • · Holdings are reported as of September 30, 2026 and the filing was submitted November 4, 2026.
  • · The information table contains two sets of line items: an initial block of holdings (reported in SH with DFND investment discretion) and a larger second block where many positions are reported with a distinct manager reference (1 = Bank Lombard Odier & Co Ltd).
  • · Several line items show zero reported value and zero shares (e.g., Intuitive Surgical, Brinker International, Entergy, Etsy, Broadcom call and put lines), which may reflect closed or expired positions or data-entry placeholders that warrant verification against the source XML.
  • · Table values appear to be reported in thousands of dollars per standard 13F convention; the raw figures should be verified against the primary XML before any amount is quoted externally.
Shoals Technologies Group, Inc. 8-K mixed materiality 9/10

04-11-2026

ARRAY Technologies (ARRY) and Shoals Technologies Group (SHLS) announced a definitive stock-for-stock merger in which ARRAY will be the legal acquirer and Shoals shareholders will receive 1.6931 ARRAY shares per Shoals share, giving Shoals holders approximately 65% of the combined company's basic shares. The combined company targets preliminary pro forma 2027 revenue of $2.2 billion to $2.4 billion and Adjusted EBITDA of $410 million to $480 million including year-one synergies, with more than $100 million of annual synergies expected within three years. ARRAY also committed to redeem $317.5 million of its Series A Perpetual Preferred Stock, and the transaction carries integration, approval, and execution risks that the release does not quantify.

  • · Initial Redemption of $161.3M at 93% of liquidation preference, to be completed within 90 days after closing
  • · Optional redemption of remaining preferred at 96% within 48 months of closing; redemptions thereafter at 100% of liquidation preference
  • · Net debt to Adjusted EBITDA expected at 2.6x at year-end 2026 and below 2x by year-end 2027
  • · Combined company does not expect to pay a material amount of cash taxes in 2027
  • · Proxy materials with additional financial details expected to be filed with the SEC by year-end
  • · Combined company intends to announce a new corporate name and ticker in coming months
  • · Transaction unanimously approved by directors of both boards who voted; Brad Forth recused from consideration and vote
  • · Pro forma and indicative ranges are not company projections, were not audited, and are not relied on by boards or financial advisors; actual results may differ materially
  • · Only about 20% of 2025-2026 projects used products from both companies, underscoring cross-selling opportunity
  • · Board of directors of the combined company will comprise ten directors
Cencora, Inc. 8-K neutral materiality 5/10

04-11-2026

Cencora, Inc. disclosed via Regulation FD Disclosure (Item 7.01) that it completed a restructuring of its operating model and will adopt a new three-part reporting structure beginning in fiscal Q1 2027: Pharmaceutical Distribution and Services, Specialty Pharmaceutical and Provider Services, and Other (non-reportable). The company furnished Exhibit 99.1 with unaudited revised segment data for each quarter of fiscal 2026 and 2025 and the full fiscal years ended September 30, 2026 and 2025, to help investors compare results under the new structure. The filing contains no quantitative financial results, so the performance impact of the restructuring cannot be assessed from this document alone.

  • · Businesses within the Other category (MWI Animal Health, Profarma, and other PharmaLex components) are being evaluated for strategic alternatives, implying possible future divestiture or sale
  • · Strategic PharmaLex components are being moved into the Specialty Pharmaceutical and Provider Services segment while the remainder sits in Other
  • · Filing is furnished under Regulation FD and is not deemed filed under Section 18 of the Exchange Act
GLR Partners, LLC 13F-HR neutral materiality 3/10

04-11-2026

GLR Partners, LLC (CIK 0002134831, Columbia, MD) filed a Form 13F-HR on November 4, 2026 reporting equity and fund holdings as of September 30, 2026. The information table lists 107 positions with a total reported value of $215,587,246 (as stated in the filing cover page, which reports the value in whole dollars). The portfolio is concentrated in large-cap growth and index-style ETFs, with the largest positions in PACER US Cash Cows 100 ETF (~$19.3M), SPDR State Street Blue Chip ETF (~$14.6M), WisdomTree US Quality Growth ETF (~$14.4M), and Vanguard Mega Cap Growth ETF (~$12.1M). Individual stock holdings include Apple, Microsoft, Meta, Alphabet, NVIDIA, and Amazon. This is a routine quarterly disclosure; the filing does not report performance changes versus a prior period, so no period-over-period comparison can be made from this document.

  • · Filing covers period ending September 30, 2026 and was filed November 4, 2026 under SEC File No. 028-26902.
  • · Portfolio is predominantly ETF-based, with a meaningful allocation to municipal bond, Treasury, gold, and fixed-income ETFs alongside equity positions.
  • · Single-name equity exposure is heavily weighted toward mega-cap technology (Apple, Microsoft, Alphabet, Meta, NVIDIA, Broadcom, Arista, KLA, Lam Research).
AZZAD ASSET MANAGEMENT INC /ADV 13F-HR neutral materiality 3/10

04-11-2026

AZZAD Asset Management Inc /ADV (Falls Church, VA; CIK 0001121914) filed its Form 13F-HR for the quarter ended September 30, 2026, disclosing equity holdings in an information table of approximately 341 line items with a reported total of roughly $1.11 billion (1,114,629,128 in thousands-of-dollars reporting as shown in the cover data). The portfolio is concentrated in large-cap technology and semiconductor names, led by Alphabet (Class A), Apple, Meta Platforms, Broadcom, and KLA Corp, alongside diversified positions in healthcare, energy, industrials, and REITs. The filing is a routine quarterly disclosure with no indication of a change in control, a buyback, or a regulatory action.

  • · Filing covers the quarter ended September 30, 2026 and was filed November 4, 2026 under Form 13F-HR (SEC File No. 028-24038).
  • · The information table in the provided excerpt is truncated at MICROCHIP TECHNOLOGY INC., so the full holdings list and total position count should be verified against the complete filing.
  • · Concentration is high in a few mega-cap names: Apple, Alphabet Class A, and Meta together account for roughly $108 million of the reported total, about 10% of the stated $1.11 billion.
  • · Semiconductor exposure (Broadcom, KLA, AMD, Lam Research, Analog Devices, Applied Materials, Coherent, MACOM) is a notable theme in the disclosed positions.
  • · The filer lists 341 holdings in its cover page, consistent with a diversified equity book spanning healthcare, energy, REITs, and industrials alongside technology.
ANDINA BOTTLING CO INC 6-K mixed materiality 6/10

04-11-2026

Andina Bottling Co Inc (AKO-B) reported a 6-K for the nine months ended September 30, 2026, showing ordinary revenue of ThCh$2,675,064,501 (up 11.8% YoY from ThCh$2,393,158,584) and net income of ThCh$198,427,878 (up 17.6% YoY from ThCh$168,746,694). However, the third quarter alone showed more moderate growth: revenue rose 12.0% to ThCh$896,608,824, but Q3 net income rose only 6.7% to ThCh$61,464,278, while Q3 financial costs increased 7.4% and cash flow from financing activities turned to a net outflow of ThCh$80,607,840 driven by dividend payments of ThCh$153,160,475. Net cash from operating activities grew 27.0% to ThCh$313,346,989, but investing outflows widened to ThCh$233,591,361 from ThCh$121,074,764.

  • · Other comprehensive income for nine months was ThCh$141,142,404 (vs ThCh$18,440,026), driven mainly by exchange rate translation gains of ThCh$179,061,600, which lifted total comprehensive income to ThCh$339,570,282.
  • · Investing outflows rose sharply, mainly from purchases of property, plant and equipment of ThCh$156,985,913 (down from ThCh$192,634,783 in 9M 2025) offset by net purchases of current financial assets of ThCh$76,580,537 versus net sales of ThCh$72,785,812 a year earlier.
  • · Bond issuance of ThCh$102,111,975 was received in 2026, against no bond issuance in the prior-year period.
  • · Other income fell 90.7% to ThCh$933,355 from ThCh$10,077,890, and gains (losses) on indexation units worsened to ThCh$(18,837,770) from ThCh$(4,057,265).
  • · Other non-financial liabilities jumped to ThCh$36,917,859 from ThCh$489,967 at year-end 2025.
  • · Q3 2026 administrative expenses grew 17.4% YoY (ThCh$163,383,141 vs ThCh$139,162,611), outpacing the 12.0% revenue growth in the quarter.
CORNERSTONE PARTNERS CAPITAL MANAGEMENT, LLC 13F-HR neutral materiality 3/10

04-11-2026

CORNERSTONE PARTNERS CAPITAL MANAGEMENT, LLC filed a Form 13F-HR for the quarter ended September 30, 2026, disclosing equity holdings across 8 securities with a reported total portfolio value of approximately $45.1 million (45122928 in thousands, as reported in the filing header). The largest positions are broad-market and sector ETFs, with the SPDR ST STR NAT ETF (324,320 shares, reported value of about $24.1 million) and the iShares CRE U S REIT ETF representing the most significant concentrations. Individual stock exposure is limited to a few names, including Space Exploration Technologies Corp. and Cerebras Systems.

  • · Filing covers the quarter ended September 30, 2026 and was filed November 4, 2026; the filer's SEC file number is 028-20905.
  • · The Space Exploration Technologies Corp. row shows 45,623 shares in the reported share column but 348,425 in the next column, an internal inconsistency in the table that warrants verification against the original filing before relying on either figure.
  • · Cerebras Systems row shows 5,496 shares total with 1,796 reported as sole-discretion shares, implying the remainder may be held under a different investment discretion arrangement not stated in the excerpt.
DIMENSIONAL FUND ADVISORS LP 13F-HR neutral materiality 3/10

04-11-2026

Dimensional Fund Advisors LP filed its Form 13F-HR for the quarter ended September 30, 2026, disclosing equity holdings across a broad universe of U.S. securities, including large positions in AT&T, AbbVie, Abbott Laboratories, and Aflac. The filing covers multiple reporting managers (Dimensional Fund Advisors Ltd., DFA Australia Ltd., Dimensional Fund Advisors Pte. Ltd., and Dimensional Ireland Ltd) and is a snapshot of holdings only, with no period-over-period comparison included in the excerpt provided.

  • · Filer is headquartered in Austin, TX (6300 Bee Cave Road, Building One); SEC file number 028-01186; period of report September 30, 2026; filed November 4, 2026
  • · Holdings are reported across four reporting managers, with the majority of positions reported under Dimensional Fund Advisors LP's SOLE voting authority, and smaller allocations attributed to affiliated entities (DFND 1 through DFND 4)
  • · Reported dollar values in the 13F information table are in thousands of dollars per standard 13F convention; the figures above are shown as reported in the raw table and have not been rescaled
  • · Excerpt provided is partial (truncated mid-table at ACUITY INC), so total portfolio value, total position count, and aggregate holdings cannot be determined from this document alone
Blackston Financial Advisory Group, LLC 13F-HR neutral materiality 3/10

04-11-2026

Blackston Financial Advisory Group, LLC (The Villages, FL) filed its Form 13F-HR for the quarter ended September 30, 2026, reporting 115 holdings with a total reported portfolio value of approximately $179,250,256 (thousands-based reporting per the filing header). The portfolio is concentrated in broad-market and sector ETFs and index funds, with the largest positions in Vanguard index and growth funds, Apple, Microsoft, and NVIDIA. The filing reports no changes in position counts versus prior periods in the provided text, so period-over-period direction cannot be assessed from this document alone.

  • · Form 13F-HR for the period ended September 30, 2026, filed November 4, 2026 under SEC File No. 028-22184
  • · Filer is based in The Villages, Florida; the filing is a Combination Report with AE Wealth Management listed as an other included manager
  • · Holdings are predominantly ETFs and index funds, with notable concentration in Vanguard vehicles
  • · Position sizes range from 10,000 shares (C4 Therapeutics) to 207,825 shares (Vanguard Mega Growth Index Fund)
  • · All positions are reported as sole investment discretion (SOLE), with no shared or other-manager voting/discretion allocations
NEOS Investment Management LLC 13F-HR neutral materiality 3/10

04-11-2026

NEOS Investment Management LLC filed its Form 13F-HR for the quarter ended September 30, 2026, reporting total 13F holdings of approximately $31.27 billion (reported as 31269182760 in the filing header) across 575 positions, all held with sole investment discretion. The filing is a routine quarterly disclosure of long equity positions; the excerpt provided does not include period-over-period comparison data, so no quarter-on-quarter change can be stated.

  • · Filer is based in Westport, CT; SEC file number 028-23457; period of report September 30, 2026; filed November 4, 2026.
  • · Largest disclosed single positions in the excerpt include Apple (~$2.09B), Amazon (~$1.11B), and Alphabet Class A (~$864M), with Advanced Micro Devices (~$858M) and Broadcom (~$719M) also large; AMD and Broadcom positions are notable in size relative to their share counts.
  • · Holdings are reported with 'SOLE' investment discretion and zero shared or other-manager voting/investment authority in the entries shown.
  • · The excerpt is truncated; the full information table (remaining positions after 'First Indl Rlty Tr') and total position count beyond the header figure are not visible.
iSHARES TRUST SC 13G/A neutral materiality 2/10

04-11-2026

Itau USA Asset Management Inc. filed an amended Schedule 13G reporting beneficial ownership of 27,286 shares of the iShares International Treasury Bond ETF (iShares Trust, CIK 0001100663) as of 10/31/2026, representing approximately 0.1% of the class. The filing is made under Rule 13d-1(b) as an investment adviser (IA) and includes a certification that the securities were acquired in the ordinary course of business and not for the purpose of influencing control of the issuer.

  • · Filing is an amendment (SCHEDULE 13G/A) filed under Rule 13d-1(b), indicating an institutional investment adviser filer; the filing reports 0 shares with sole/shared dispositive power as zero in the shared columns and 27,286 sole power as stated.
  • · Filing references a prior accession number (0001541597-26-000003) in the form header of the primary document, suggesting this is an update to an earlier 13G report.
  • · Filer is a Delaware-incorporated entity located at 599 Lexington Avenue, New York, NY, while the issuer's business address is San Francisco, CA.
  • · Shares are held across five separately identified accounts, with the largest single account (ESP_SMASOL60) holding 16,084 shares.
Quadrant Private Wealth Management, LLC 13F-HR neutral materiality 3/10

04-11-2026

Quadrant Private Wealth Management, LLC (CIK 0001727454, Center Valley, PA) filed a Form 13F-HR on November 4, 2026 reporting its equity holdings as of September 30, 2026. The information table lists 327 holdings with a reported total portfolio value of $753,379,446 (figure as stated in the filing cover page summary), dominated by ETF positions, with large allocations to Alphabet, Meta, Blackstone-related vehicles, and broad-market iShares and Vanguard funds. The filing contains only current-period holdings, so no period-over-period comparison can be derived from this document.

  • · Filing covers holdings as of September 30, 2026 and was filed November 4, 2026 under accession number 0001725547-26-000393
  • · All reported positions are held with sole investment discretion (SOLE voting authority, zero shared or none)
  • · Largest single positions by market value include Alphabet Class C (~$17.5M), Meta Platforms Class A (~$16.3M), and iShares S&P 500 Growth ETF (~$15.1M)
  • · Portfolio includes a Bitcoin exposure via iShares Bitcoin Trust ETF (~$1.27M) and Grayscale Bitcoin Trust ETF (~$1.01M)
  • · Filing shows a non-trivial allocation to private/non-traded vehicles, including BlueRock Private Real Estate Fund (~$34.3M) and Blackstone Secured Lending Fund (~$4.9M)
Seres Therapeutics, Inc. 10-Q negative materiality 8/10

04-11-2026

Seres Therapeutics reported a net loss of $16.3M for Q3 2026 (versus net income of $8.2M in Q3 2025) and a nine-month net loss of $31.6M (versus net income of $21.0M). Results were driven by the absence of the prior-year VOWST sale gain, a $5.7M impairment charge in Q3 and $11.5M year-to-date, and lower R&D and G&A spend. Cash, cash equivalents and restricted cash fell to $20.7M at September 30, 2026, down from $54.4M at December 31, 2025, with a nine-month operating cash outflow of $49.2M.

  • · Nine-month 2026 operating cash burn of $49.2M contrasts with $15.8M of operating cash generation in 2025, reflecting the loss of the VOWST business and lower collections
  • · Operating lease liabilities fell sharply (total from $82.97M to $35.77M), largely from a $30.4M reduction due to lease modification
  • · Leasehold improvements dropped from $30.95M to $3.75M and accumulated depreciation fell, consistent with asset disposals and the impairment charges
  • · Accounts receivable from SPN related party was $12.5M at 9/30/2026, versus $0.36M at 12/31/2025, tied to the VOWST milestone termination payment received in the period
  • · Equity raised via at-the-market offerings was modest ($2.9M net in nine months), with 103,520 shares issued for lease termination valued at $0.5M
  • · Going-concern-style liquidity pressure is implied by cash of $17.5M against a nine-month operating burn of $49.2M, though the filing text itself was not provided to confirm management's conclusions
Dalton Investments, Inc. 13F-HR neutral materiality 4/10

04-11-2026

Dalton Investments, Inc. filed its Form 13F-HR for the quarter ended September 30, 2026, disclosing 14 equity positions with an aggregate reported value of $149,067,909 (table values are in US dollars as reported under the 13F format). Largest reported positions include TaskUs Inc (about $33.7M), NVIDIA (about $45.7M), Cognizant (about $22.4M), Genpact (about $16.3M) and HDFC Bank (about $15.8M). Holdings are concentrated in technology and outsourcing services alongside a smaller group of small-cap energy names, and the filing shows no change-in-direction data on its own, so the quarter-over-quarter trend cannot be assessed from this document.

  • · Filing is a 13F-HR for period ending 09-30-2026, filed 11-04-2026 under SEC file number 028-12151
  • · All 14 positions are reported with sole investment discretion and no shared or other-manager voting authority
  • · Energy holdings (Amplify, Chord, Epsilon, Kosmos) total roughly $4.2M, a small share of the portfolio
  • · The information table lists no put/call options, so all positions are common equity or ADS holdings
  • · Filing does not include prior-period values, so no period-over-period change can be calculated from this document
AVALON CAPITAL MANAGEMENT 13F-HR neutral materiality 5/10

04-11-2026

AVALON CAPITAL MANAGEMENT (CIK 0001510809, Menlo Park, CA) filed its Form 13F-HR on November 4, 2026, reporting equity holdings as of September 30, 2026. The filing lists 130 positions with a combined reported market value of approximately $434.4 billion (434,395,013 thousand USD), concentrated in large-cap technology, ETFs, and precious-metals/mining exposures. The filing contains only current-period holdings, so no period-over-period comparison is available.

  • · Largest single holding by reported value is SPDR Gold Trust at ~$25.6B (67,096 shares); Alphabet Class A (~$50.0B) and Alphabet Class C (~$21.2B) combined are roughly $71.3B, making Alphabet the largest single-issuer exposure
  • · Filing reports 5,000 call options on Global X Uranium ETF, 2,500 call options on VanEck Uranium & Nuclear ETF, and 5,000 put options on SPDR S&P 500 ETF, indicating some derivative positioning alongside the core equity book
  • · Sizable ETF concentration including Schwab U.S. Small-Cap ETF (~$11.2B), VanEck Semiconductor ETF (~$23.0B), VanEck Gold Miners ETF (~$30.4B), and SPDR Energy Select (~$11.2B)
  • · Precious metals and mining exposure is substantial across ETFs and direct equities (Gold Miners ETF, Silver ETF, Hecla, Agnico Eagle, Wheaton, Pan American Silver)
  • · Filing identifies the company as Form 13F-HR filer with SEC file number 028-14108, filed as of November 4, 2026; formerly named David R. Rahn & Associates Inc.
Karnit Road Accident Victims Compensation Fund 13F-HR neutral materiality 3/10

04-11-2026

Karnit Road Accident Victims Compensation Fund, an Israeli statutory compensation fund, filed its Form 13F-HR for the quarter ended September 30, 2026, reporting 20 holdings with an aggregate reported market value of $163,558,084 (as stated in the filing header table total). The portfolio is concentrated in broad-market and sector ETFs, led by large positions in the SPDR S&P 500 ETF and Vanguard S&P 500 ETF, and includes international, factor, and hedged-equity exposures. The filing states that certain dual-listed securities were included only where purchased in the U.S., and that the filer disclaims beneficial ownership of the reported securities.

  • · Largest single positions are the SPDR S&P 500 ETF Trust (110,942 shares, ~$84.6M) and Vanguard S&P 500 ETF (82,377 shares, ~$57.7M), together representing roughly 87% of the reported total value.
  • · Holdings are predominantly ETFs with voting/investment discretion shown as SOLE for most lines and OTR (other) for the two S&P 500 ETF positions.
  • · Filing notes use of third-party portfolio managers for some investment and voting decisions and a disclaimer of beneficial ownership on behalf of the public served by the fund.
Clarion Partners Real Estate Income Fund Inc. SC 13D/A neutral materiality 6/10

04-11-2026

Franklin Templeton, Inc. (formerly Franklin Resources, Inc.), together with principal stockholders Charles B. Johnson and Rupert H. Johnson, Jr., filed an amended Schedule 13D reporting beneficial ownership of 93,329 Class S Shares of Clarion Partners Real Estate Income Fund Inc., representing 48.2% of the 193,498 shares outstanding as of November 3, 2026. The position rose after FTI purchased 88,106 shares on April 16, 2026 at $11.35 per share, for a total of $1,051,085, from working capital; the Johnsons themselves report no direct holdings.

  • · FTI acquired the shares to maintain capitalization and liquidity and to facilitate acquisition of the Issuer's commercial real estate investments; the filing also cites an investor rebalancing its holdings as context for the purchase
  • · Reporting persons state they may increase or decrease their position depending on market conditions, the Issuer's financial position and prospects, and share prices, but currently have no plans relating to the actions listed in Item 4(a)-(j)
  • · The Johnsons disclaim beneficial ownership of the shares and state they are not a 'group' under Rule 13d-5
  • · Franklin Resources, Inc. was renamed Franklin Templeton, Inc. effective August 17, 2026
Curran Financial Partners, LLC 13F-HR neutral materiality 3/10

04-11-2026

Curran Financial Partners, LLC (Daniel Island, SC; CIK 0001843867) filed a Form 13F-HR on November 4, 2026 reporting its institutional equity holdings as of September 30, 2026. The filing lists 143 holdings with a total reported value of approximately $615,411,311 (in thousands-reported format, reproduced here as the source figure of 615411311). The portfolio is concentrated in large-cap technology, ETFs, and index-tracking funds, with Apple, NVIDIA, Microsoft, and Amazon among the largest single positions by reported value. The filing contains no prior-period comparison, so no period-over-period change can be calculated from this document.

  • · Filing covers holdings as of September 30, 2026 and was filed November 4, 2026 under accession number 0001843867-26-000006.
  • · Portfolio is heavily weighted toward ETFs and index funds, with a large number of fund positions (e.g., Vanguard, iShares, SPDR, Schwab) alongside direct equity holdings.
  • · Largest single-stock positions by reported value include Apple, NVIDIA, Microsoft, and Amazon.
  • · The Yorkville America Investment Trust (Truth Social Group ETF) position reports 1,945,000 shares with a notably unusual share-to-value relationship that warrants verification against the primary XML.
  • · The filing is a holdings report only; it does not disclose trading activity, performance, or changes from prior quarters, so no period-over-period analysis is possible.
  • · Reported values are as shown in the source text; units (typically thousands of dollars in 13F filings) should be confirmed against the official information table before publication.
5C Lending Partners Corp. 10-Q mixed materiality 8/10

04-11-2026

5C Lending Partners Corp. reported total investment income of $20,656 thousand for Q3 2026, up from $6,766 thousand in Q3 2025, and net increase in net assets from operations of $11,867 thousand. Total net assets rose to $432,915 thousand at September 30, 2026 from $241,306 thousand at December 31, 2025, driven by common stock issuance, while NAV per common share declined to $24.57 from $25.24. Net change in unrealized losses for the nine months (-$12,219 thousand) and a $(2,118) thousand accumulated distributable loss weigh on results, even as net investment income expanded sharply.

  • · Net investment income for Q3 2026 was $9,166 thousand versus $1,142 thousand in Q3 2025, but nine-month net investment income of $17,807 thousand reflects a more modest pace of earnings growth relative to the quarter.
  • · Net change in unrealized losses on non-controlled, non-affiliated investments was $(13,838) thousand for the nine months 2026, reversing a $1,054 thousand gain in the prior-year period.
  • · Cash and cash equivalents declined to $8,181 thousand from $137,048 thousand, and net cash used in operating activities was $(516,535) thousand for the nine months, driven by $568,069 thousand of investment purchases and originations.
  • · ABL Credit Facility borrowings rose to $467,000 thousand from $170,000 thousand at year-end 2025, while the Credit Facility declined to $95,769 thousand from $181,968 thousand.
  • · Preferred Stock dividends of $139 thousand for nine months and Q3 2026 Preferred Stock dividends of $46 thousand were paid, with 515 preferred shares outstanding.
  • · The KPCI Holdings Ltd. (PCI Pharma Services) preferred equity position of $58,441 thousand represents 13.55% of net assets applicable to common stock and carries an 11.00% PIK rate.
  • · Flexera Software LLC term loans, Navex Global, and Starlight Parent (SolarWinds, second lien at 9.68% of net assets) are among the largest debt exposures.
M&G Plc 13F-HR neutral materiality 3/10

04-11-2026

M&G Plc filed a Form 13F-HR for the quarter ended September 30, 2026, disclosing its US-listed equity and convertible note holdings across a large, diversified portfolio spanning technology, healthcare, energy, financials, and real estate. The filing is a routine regulatory disclosure of institutional holdings rather than a company-specific corporate event, and the excerpt provided does not include aggregate portfolio totals or period-over-period comparisons, so no performance trend can be assessed from it.

  • · Filing covers the quarter ended September 30, 2026, filed November 4, 2026, under SEC file number 028-24119.
  • · Holdings include convertible notes issued by Alibaba, Coinbase, CyberArk, Datadog, Box, Live Nation, Lanthas, and others, indicating meaningful fixed-income/convertible exposure alongside equities.
  • · Several positions carry both sole and shared/other investment discretion (e.g., Accenture, Agilent, Broadcom, Amcor), with a portion of holdings managed under a second manager (Form 13F 'Other Included Manager' reference 2).
  • · The excerpt shows put options on Advanced Energy Industries (13,800 shares), indicating use of derivatives for hedging or directional positioning.
  • · Largest single positions in the excerpt by market value include Amcor PLC (~$1.11B), Broadcom (~$636M), and CME Group (~$348M), though no portfolio-wide total is available in the excerpt to assess concentration.
Soundwatch Capital LLC 13F-HR neutral materiality 3/10

04-11-2026

Soundwatch Capital LLC (Dallas, TX; CIK 0001803253) filed its Form 13F-HR for the quarter ended September 30, 2026, reporting 51 holdings in the information table with an aggregate market value of approximately $910.7 million ($910,655,849 in thousands per the reported total). The portfolio is dominated by broad-market and passive equity ETFs, led by iShares Core S&P 500 ETF and State Street SPDR S&P 500 ETF, with individual stock positions such as Apple, NVIDIA, and Microsoft comprising a smaller share. The filing is a holdings disclosure only and contains no comparative period data.

  • · Filing covers the quarter ended September 30, 2026 and was filed November 4, 2026 under SEC file number 028-20153
  • · Filing is signed by Jan Bos, Chief Investment Strategist, dated November 3, 2026, from Rowayton, CT
  • · Information table is submitted by an other included manager, United Capital Financial Advisors, LLC (CIK 0001463217, file 028-13508), with investment discretion exercised as 'OTR' (other) and no voting authority reported in the sole/shared/none columns
  • · Portfolio is heavily concentrated in ETFs and index-tracking vehicles rather than single-company equity positions
  • · Largest single-line positions by value are the State Street SPDR S&P 500 ETF (~$395.9B reported value line), iShares Core S&P 500 ETF (~$383.1B reported value line), and Apple Inc. (~$19.9B)
  • · Filing contains no prior-period comparison, so quarter-over-quarter changes in holdings cannot be assessed from this document alone
UNIFI INC 10-Q mixed materiality 6/10

04-11-2026

UNIFI Inc. reported net sales of $127.9M for the quarter ended September 27, 2026, down 5.7% from $135.7M a year earlier, while the net loss narrowed to $2.0M ($0.11 per share) from $11.4M ($0.62 per share). Gross profit more than tripled to $12.5M (gross margin rising to 9.8% from 2.5%), driven by lower cost of sales, and operating loss improved to near break-even from a $9.6M loss. However, REPREVE® Fiber sales fell 7.2% year over year to $36.4M, and all other products declined 5.1% to $91.5M, while inventories rose 8.1% sequentially to $109.2M and bad-debt provisions increased to $0.6M from a $0.1M benefit.

  • · Restructuring costs were nil in the quarter versus $1.1M in the prior-year quarter.
  • · Foreign currency translation adjustments contributed $0.2M to other comprehensive income, versus $2.2M a year earlier.
  • · Accounts payable rose to $37.5M from $31.2M, and other current liabilities declined to $15.2M from $17.2M.
  • · Current portion of long-term debt was $12.1M and non-current long-term debt $78.8M at September 27, 2026, down from $12.4M and $80.0M at June 28, 2026.
  • · ABL Revolver net repayments were $(1.7)M in the quarter, versus net repayments of $(11.6)M in the prior-year quarter.
  • · Depreciation and amortization was $5.8M, slightly below $6.0M a year earlier.
  • · Retained earnings declined to $212.5M from $214.5M sequentially, reflecting the quarterly net loss.
Running Oak Capital LLC 13F-HR neutral materiality 3/10

04-11-2026

Running Oak Capital LLC (Edina, MN) filed its Form 13F-HR for the quarter ended September 30, 2026, reporting 116 holdings with a combined reported value of approximately $605.9 million (value field 605860162, reported in thousands). The portfolio is concentrated in mid- and large-cap U.S. and Irish/Swiss-domiciled equities across industrials, healthcare, technology, financials and consumer sectors, with most positions held as sole-discretion shares. Because this is a holdings disclosure rather than a corporate event, it contains no reported change in performance metrics versus a prior period.

  • · Filing is a 13F-HR holdings report for the period ended 09-30-2026, filed 11-04-2026 under SEC file number 028-20193; the filer is based at 4519 W 56th St, Edina, MN.
  • · Holdings are split between 'OTR' (other-reporting/shared) and 'SOLE' investment discretion; roughly 80–85% of each position's shares are reported under SOLE discretion (e.g., Tractor Supply: 215,729 SOLE vs. 86,980 OTR shares).
  • · Largest reported positions by value include Tractor Supply (~$10.3M combined), IQVIA (~$16.0M combined), ServiceNow (~$14.8M combined) and Zebra Technologies (~$16.9M combined); no single position appears to exceed roughly 3% of total reported value.
  • · Filing reports 'Other Included Managers' count of 0, indicating the 13F is filed on a standalone basis without co-managers included.
Midwest Capital Advisors, LLC 13F-HR neutral materiality 3/10

04-11-2026

Midwest Capital Advisors, LLC (Grand Rapids, MI; CIK 0002026480) filed its Form 13F-HR for the quarter ended September 30, 2026 on November 4, 2026, reporting 233 holdings with an aggregate reported market value of approximately $279.5 billion. The portfolio is concentrated in broad-market and sector ETFs, with large positions in BlackRock iShares, Schwab Strategic Trust, Vanguard and Global X funds, alongside sizable single-stock holdings in NVIDIA, Apple, Microsoft and Alphabet. The filing is a routine quarterly disclosure of holdings and contains no explicit period-over-period comparison.

  • · Filing is a Form 13F-HR (SEC file no. 028-24738) covering the period ended September 30, 2026, with Mark R. Satkoski signing as Chief Compliance Officer
  • · Information table is dominated by ETF positions, which account for the large majority of the reported aggregate value; single-stock holdings are comparatively small and include NVIDIA (~$1.45B), Apple (~$431M) and Microsoft (~$364M)
  • · Filing reports no prior-period comparison, so quarter-over-quarter changes in positions cannot be assessed from this document alone
  • · Several positions are very small (e.g., American Bitcoin Corp. at $25 thousand, Bumble at $3 thousand, Charles Schwab at $99 thousand), indicating residual or tail holdings

Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: US SEC Filings Daily Market Digest

🇺🇸 More from United States

View all →